Good governance is the key to sustainable success. At IWT, we ensure compliance with national and international standards through a robust system of policies and procedures aligned with our Code of Conduct.
We promote:
- Transparency and accountability
- Ethical business practices
- Respect for stakeholders and communities
Our approach strengthens trust, supports long-term relationships, and sustains value creation across the pharmaceutical supply chain.
Quality is the foundation of everything we do. Our Quality Management System, certified ISO 9001:2015, ensures the highest product reliability and customer satisfaction across all departments—from design and production to installation and global service.
Through innovation, process control, and validation support, IWT guarantees cGMP-compliant solutions tailored to the most demanding pharmaceutical environments.
We select suppliers based not only on quality and performance, but also on their sustainability practices. Our procurement strategy promotes:
- Transparent, long-term relationships
- Shared environmental and social values
- Continuous improvement in ESG performance
We encourage our partners to align with our values and support the development of a responsible and resilient supply chain.
In today’s increasingly complex and ever-changing global landscape, we adopt a structured Enterprise Risk Management (ERM) approach to proactively assess the potential impacts of our operations, regulatory changes, and evolving market dynamics.
Security - both physical and digital - is a key priority. We implement advanced protection systems and access control measures, ensuring the highest level of protection for the company’s critical assets and stakeholder data.
Information is classified according to its level of sensitivity and managed through rigorous internal procedures, guaranteeing compliance with the highest standards of confidentiality and data protection.
These practices enable us to operate safely, transparently, and responsibly, contributing to the development of a robust and sustainable pharmaceutical value chain.
CORPORATE
ITALY
FRANCE
GERMANY
UK
CHINA